Ortho-Est Oral Tablet 0.75Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ortho-Est: Oral tablet (0.75mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_5520.JPG
Ortho-Est 0.75mg Tab
Janssen Pharmaceuticals, Inc, formerly Ortho Womens Health & Urology, Division of
Pill Identification: WFHC 101 
Drug Image file DrugItem_4664.JPG
Ogen .625 Tab
Pfizer US Pharmaceuticals
Pill Identification: U 3772  |  U 3772
Drug Image file DrugItem_1054.JPG
Estropipate 0.75mg Tab
Duramed Pharmaceuticals Inc a Division of Teva USA
Drug Image file DrugItem_3861.JPG
Estropipate 0.75mg Tab
Barr Laboratories Inc a Division of Teva USA
Pill Identification: barr  |  555 727
Drug Image file DrugItem_4372.JPG
Ortho-Est 0.75mg Tab
Women First Healthcare Inc
Pill Identification: WFHC 101 
Drug Image file DrugItem_15057.JPG
Estropipate 0.75mg Tab
Mylan Pharmaceuticals Inc
Pill Identification: M E7 
Drug Image file DrugItem_1735.JPG
Estropipate 0.75mg Tab
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: WATSON 414 

What is this Medicine?

ESTROPIPATE (es troe PIH pate) is an estrogen. It is mostly used as hormone replacement in menopausal women. It helps to treat hot flashes and prevent osteoporosis. It is also used to treat women with low hormone levels.

In-Depth Information
Select a Medication

Ortho-Est 0.75mg Tablet

NDC: 642480101
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Menopause, Oophorectomy, Hypogonadism, Hot Flashes, Osteoporosis Prophylaxis, Atrophic Vaginitis, Ovarian Failure

Ortho-Est 0.75mg Tablet
Drug Image file DrugItem_4372.JPG
Women First Healthcare Inc
Pill Identification: WFHC 101 
Shape: diamond
Color: white

Reported Side Effects for Ortho-Est 0.75mg Tablet

Endometrial Hyperplasia Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Weight Gain Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Menstrual Cramps Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Breast Pain Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Breakthrough Bleeding Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Ortho-Est 0.75mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Minor Lifestyle Interaction
Grapefruit juice and Ortho-Est 0.75mg Tablet(Estropipate)
Grapefruit juice and Estrogens(Estropipate)
Grapefruit juice and grapefruit-containing foods may increase the side effects of estrogen in some females, such as nausea, breast tenderness, headache or fluid retention. There may be no interaction. Do not significantly change your grapefruit intake while taking estrogens for hormone replacement therapy or as part of hormonal birth control products. Report any unusual side effects, like unusual non-menstrual vaginal bleeding, promptly for evaluation.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ortho-Est

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5